LBF20207PG46
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1788 |
LipidMaps | - |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG46 |
8-iso Prostaglandin F_2α | |
---|---|
Structural Information | |
9α,11α,15S-Trihydroxy- (8β) -prosta-5Z,13E-dien-1-oic acid | |
| |
Formula | C20H34O5 |
Exact Mass | 354.240624198 |
Average Mass | 354.48096000000004 |
SMILES | C(CC[C@H](O)C=C[C@H]([C@@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)CC |
Physicochemical Information | |
In normal human urine, 8-iso PGF2 alpha level are about 180-200 pg/mg of creatinine. Morrow_JD et al. | |
8-iso PGF2 alpha is reported to inhibit platelet aggregation induced by U-46619 (1 mu M) and I-BOP (0.3 mu M) with IC50 of 1.6 mu M and 1.8 mu M, respectively. Morrow_JD et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|